Palo Alto Networks: Walking A Tightrope Between Growth And Valuation
We warn of potential downside risk for Palo Alto Networks (PANW) stock due to high expectations and bearish outlook in the ...
MiBolsilloColombia on MSN7h
What do we know about the SSA WEP and GPO repeal?
The Social Security Fairness Act promises to enhance benefits for millions, but its implementation may take over a year due ...
stocknews15h
3 Cloud Security Stocks Benefiting from the Remote Work Boom
With remote work becoming the new norm, cyber threats are escalating at an alarming rate. This growing risk is driving demand ...
Securing 5G edge network – what companies should know before stepping on the edge of tech
In today's digital landscape, data processing can occur either at centralized locations like data centers and on-premise ...
CRN19h
SentinelOne Channel Chief On Massive Cloud Security, ‘AI SIEM’ Opportunities
SentinelOne is making a major push this year around AI-powered SIEM, as well as cloud and data security, Channel Chief Brian ...
TMCnet20h
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
Trial Met the Primary Endpoint and Provides Evidence of GTx-104 Clinical Benefit Compared to Orally Administered Nimodipine. New Drug Application (NDA) Submission Expected in the ...
PharmiWeb21h
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
Boehringer Ingelheim announced today that the FIBRONEERâ„¢-ILD trial met its primary endpoint, which was the absolute change from baseline in forced vital capacity (FVC) [mL] at week 52 versus placebo.